ICON

Overview

ICON plc is a global healthcare intelligence and clinical research organization based in Ireland, specializing in the business services industry, particularly in research and development within the healthcare, biotech, and pharmaceutical sectors. Founded in 1990, the company employs over 10,000 individuals and reported significant revenue in the billions. ICON's recent publication, a whitepaper titled “Optimising biotech funding,” highlights the current trends and challenges faced by biotech companies, particularly regarding their research and development (R&D) spending. The whitepaper indicates that a majority of surveyed biotech executives anticipate increasing their R&D expenditures, despite acknowledging the complexities and financial constraints associated with clinical trials. The document emphasizes the necessity for biotech firms to establish strategic partnerships with larger pharmaceutical companies and contract research organizations (CROs) to enhance their development strategies and funding opportunities. ICON’s insights reflect a commitment to addressing the evolving landscape of biotech funding and the operational challenges that impact innovation in the industry.

Industry